SCHEMBL14696371

SCHEMBL14696371

CC(N)NC(=O)CCCCC1CCSS1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.61
▸ TARDBP Q13148 2/20 0.61
▸ ACHE P22303 3/20 0.57
▸ HSD17B10 Q99714 2/20 0.57
▸ CYP2C9 P11712 1/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ NR1I2 O75469 1/20 0.57
▸ ALDH1A1 P00352 1/20 0.57
▸ LMNA P02545 1/20 0.57
▸ POLB P06746 1/20 0.57
▸ THRB P10828 1/20 0.57
▸ TSHR P16473 1/20 0.57
▸ APEX1 P27695 1/20 0.57
▸ RECQL P46063 1/20 0.57
▸ BLM P54132 1/20 0.57
▸ PMP22 Q01453 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ SAE1 Q9UBE0 1/20 0.57
▸ UBA2 Q9UBT2 1/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2378783 0.89 KMT2A (0.60) KMT2ATARDBPACHEHSD17B10CYP2C9
SCHEMBL15892712 0.89 KMT2A (0.60) KMT2ATARDBPACHEHSD17B10CYP2C9
SCHEMBL7840541 0.85 ACHE (0.56) KMT2ATARDBPACHEHSD17B10CYP2C9
SCHEMBL17265764 0.85 HSD17B10 (0.60) KMT2ATARDBPACHEHSD17B10CYP2C9
SCHEMBL8516625 0.85 HSD17B10 (0.60) KMT2ATARDBPACHEHSD17B10CYP2C9
SCHEMBL19160060 0.85 ACHE (0.64) KMT2ATARDBPACHEHSD17B10CYP2C9
SCHEMBL7843952 0.85 HSD17B10 (0.60) KMT2ATARDBPACHEHSD17B10CYP2C9
SCHEMBL18503015 0.85 HSD17B10 (0.60) KMT2ATARDBPACHEHSD17B10CYP2C9
SCHEMBL7843950 0.85 HSD17B10 (0.60) KMT2ATARDBPACHEHSD17B10CYP2C9
SCHEMBL21049779 0.84 ACHE (0.55) KMT2ATARDBPACHEHSD17B10CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9304124-B2 Compact multifunctional ligand to enhance colloidal stability of nanoparticles THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2016-04-05 — — US disclosed
US-20130323777-A1 Compact Multifunctional Ligand to Enhance Colloidal Stability of Nanoparticles NAVAL RESEARCH LABORATORY (US) 2013-12-05 — — US disclosed
US-8512755-B2 Compact multifunctional ligand to enhance colloidal stability of nanoparticles THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2013-08-20 — — US disclosed
WO-2013025347-A1 COMPACT MULTIFUNCTIONAL LIGAND TO ENHANCE COLLOIDAL STABILITY OF NANOPARTICLES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2013-02-21 — — WO disclosed
US-20130045499-A1 Compact Multifunctional Ligand to Enhance Colloidal Stability of Nanoparticles THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2013-02-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130045499-A1 Compact Multifunctional Ligand to Enhance Colloidal Stability of Nanoparticles EPCAM, SLC7A1, CAD KMT2A 3053/4885TARDBP 1420/4885ACHE 2529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback